Individualizing Treatment With SGLT-2 Inhibitor Therapy in Type 2 Diabetes Mellitus

被引：0
|
作者：
Miller, Eden M.
机构：
来源：
JOURNAL OF FAMILY PRACTICE | 2017年 / 66卷 / 02期
关键词：
CARDIOVASCULAR OUTCOMES; POOLED ANALYSIS; SAFETY; EMPAGLIFLOZIN; ROSIGLITAZONE; TOLERABILITY; ASSOCIATION; MANAGEMENT; STATEMENT; EVENTS;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S13 / S16
页数：4
相关论文
共 50 条
  • [21] SGLT-2 inhibitors as second-line therapy in type 2 diabetes
    Tahrani, Abd A.
    LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (09): : 678 - 679
  • [22] An SGLT-2 inhibitor reverses impaired ventricular repolarisation in patients with type 2 diabetes
    Sato, T.
    Miki, T.
    Ohnishi, H.
    Yamashita, T.
    Takada, A.
    Yano, T.
    Tanno, M.
    Tsuchida, A.
    Miura, T.
    DIABETOLOGIA, 2017, 60 : S424 - S425
  • [23] Empagliflozin, an SGLT2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus: A Review of the Evidence
    White, John R., Jr.
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (05) : 582 - 598
  • [24] SGLT-2 Inhibitors in Type 1 Diabetes Mellitus: A Comprehensive Review of the Literature
    Patoulias, Dimitrios
    Imprialos, Konstantinos
    Stavropoulos, Konstantinos
    Athyros, Vasilios
    Doumas, Michael
    CURRENT CLINICAL PHARMACOLOGY, 2018, 13 (04): : 261 - 272
  • [25] SGLT-2 inhibition with canagliflozin: A new option for the treatment of type 2 diabetes
    Seufert, J.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 : S52 - S58
  • [26] SGLT-2 inhibitors as adjunctive to insulin therapy in type 1 diabetes
    Maj-Podsiadlo, Anna
    Cichocka, Edyta
    Gumprecht, Janusz
    CLINICAL DIABETOLOGY, 2020, 9 (03): : 189 - 192
  • [27] Risk of fracture associated with SGLT-2 inhibitors as an add-on therapy to metformin in patients with type 2 diabetes mellitus
    Yang, Hyeri
    Choi, Eunmi
    Kim, Bonggi
    Chung, Soo Youn
    Han, Soon Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 329 - 329
  • [28] Effect of Glomerular Filtration Rate on Uric Acid Metabolism in a Retrospective Cohort of Type-2 Diabetes Mellitus Patients on SGLT-2 Inhibitor Therapy
    Vuraloglu, Emre
    Kut, Altug
    Iyidir, Ozlem Turhan
    JOURNAL OF CLINICAL PRACTICE AND RESEARCH, 2025, 47 (01): : 11 - 20
  • [29] Euglycaemic diabetic ketoacidosis in a 43-year-old woman with type 2 diabetes mellitus on SGLT-2 inhibitor (empagliflozin)
    Latif, Azka
    Gastelum, Aheli Arce
    Sood, Akshat
    Reddy, Joseph Thilumala
    BMJ CASE REPORTS, 2020, 13 (06)
  • [30] SGLT-2 inhibitors on cardiac autonomic function in individuals with and without type 2 diabetes mellitus
    Ozel, Hasan Fehmi
    Alpay, Suheda
    Asker, Emre
    Gultekin, Elif Sidal
    Kazdagli, Hasan
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2025, 39 (05)
12345